IL-1beta-induced iNOS expression, NO release and loss in metabolic cell viability are resistant to inhibitors of ceramide synthase and sphinogomyelinase in INS 832/13 cells

Journal of the Pancreas

Volumn 7, Issue 6, 2006, Pages 593-601

  Veluthakal, Rajakrishnan ^a,b   Jangati, Giridhar Rao ^a,b   Kowluru, Anjaneyulu ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Ceramides; Insulin secreting cells; Interleukin 1; Nitric oxide synthase type II; Sphingomyelin phosphodiesterase

Indexed keywords

3 O METHYLSPHINGOMYELIN; ACYLTRANSFERASE INHIBITOR; CERAMIDE; DESIPRAMINE; FUMONISIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; INTERLEUKIN 1BETA; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITOR; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELIN PHOSPHODIESTERASE INHIBITOR; SPHINGOSINE ACYLTRANSFERASE; SPHINGOSINE ACYLTRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG SELECTIVITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INSULIN RELEASE; LIPOGENESIS; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CELL SURVIVAL; DRUG RESISTANCE; INSULIN-SECRETING CELLS; INTERLEUKIN-1BETA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OXIDOREDUCTASES; RATS; SPHINGOMYELIN PHOSPHODIESTERASE;

EID: 33751082356     PISSN: 15908577     EISSN: 15908577     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Corbett JA, Sweetland MA, Wang JL, Lancaster JR, McDaniel ML. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci USA 1993; 90:1731-5 [PMID 8383325]
2. Cunningham JM, Green IC. Cytokines, nitric oxide and insulin-secreting cells. Growth Regul 1994; 4:173-80. [PMID 7756973]
3. Kowluru A, Morgan NG. GTP-binding proteins in cell survival and demise: the emerging picture in the pancreatic beta cell. Biochem Pharmacol 2002 ;63:1027-35. [PMID 11931834]
4. Chen HQ, Tannous M, Veluthakal R, Amin R, Kowluru A. Novel roles for palmitoylation of Ras in IL-1beta-induced nitric oxide release and caspase activation in insulin-secreting beta cells. Biochem. Pharmacol 2003; 66:1681-94. [PMID 14563479]
5. Veluthakal R, Chvyrkova I, Tannous M, McDonald P, Hadden T, Thurmond D, et al. Essential role for membrane lipid rafts in IL-1beta-induced nitric oxide release from insulin-secreting cells: potential regulation by caveolin-1. Diabetes 2005; 54:2576-85. [PMID 16123345]
6. Veluthakal R, Palanivel R, Zhao Y, McDonald P, Gruber S, Kowluru A. Ceramide induces mitochondrial abnormalities in insulin-secreting INS-1 cells: potential mechanisms underlying ceramide-mediated metabolic dysfunction of the beta cell. Apoptosis 2005; 10:841-50. [PMID 16133874]
7. Veluthakal R, Amin R, Kowluru A. Interleukin-1 beta induces posttranslational carboxymethylation and alterations in subnuclear distribution of lamin B in insulin-secreting RINm5F cells. Am J Physiol Cell Physiol 2004; 287:C1152-62. [PMID 15201138]
8. Tannous M, Amin R, Popoff MR, Fiorentini C, Kowluru A. Positive modulation by Ras of interleukin-1beta-mediated nitric oxide generation in insulin-secreting clonal beta (HIT-T15) cells. Biochem Pharmacol 2001; 62:1459-68. [PMID 11728382]
9. Kwon G, Corbett JA, Rodi CP, Sullivan P, McDaniel ML. Interleukin 1beta-induced nitric oxide synthase expression by rat pancreatic beta cells: evidence for the involvement of nuclear factor kappa B in the signaling mechanism. Endocrinology 1995; 136:4790-5. [PMID 7588208]
10. Lee JT, Xu J, Lee JM, Ku G, Han X, Yang DI, et al. Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J Cell Biol 2004; 164:123-31. [PMID 14709545]
11. Won JS, Im YB, Khan M, Singh AK, Singh I. The role of neutral sphingomyelinase produced ceramide in lipopolysaccharide-mediated expression of inducible nitric oxide synthase. J Neurochem 2004; 88:583-93. [PMID 14720208]
12. Lister MD, Ruan ZS, Bittman R. Interaction of sphingomyelinase with sphingomyelin analogs modified at the C-1 and C-3 positions of the sphingosine backbone. Biochim Biophys Acta 1995; 1256:25-30. [PMID 7742352]
13. Pilane CM, LaBelle EF. NO induced apoptosis of vascular smooth muscle cells accompanied by ceramide increase. J Cell Physiol 2004; 199:310-5. [PMID 15040013]
14. Xu J, Yeh CH, Chen S, He L, Sensi SL, Canzoniero LMT, et al. Involvement of de novo ceramide biosynthesis in tumor necrosis factor-alpha/ cycloheximide-induced cerebral endothelial cell death. J Biol Chem 1998; 273:16521-6. [PMID 9632721]
15. Lovat PE, Di Sano F, Corazzari M, Fazi B, Donnorso RP, Pearson AD, et al. Gangliosides link the acidic sphingomyelinase-mediated induction of ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma in response to fenretinide. J Natl Cancer Inst 2004, 96:1288-99. [PMID 15339967]
16. Desai K, Sullards MC, Allegood J, Wang E, Schmelz EM, Hartl M, et al. Fumonisins and fumonisin analogs as inhibitors of ceramide synthase and inducers of apoptosis. Biochim Biophys Acta 2002; 1585:188-92. [PMID 12531553]
17. Erdreich-Epstein A, Tran LB, Bowman NN, Wang H, Cabot MC, Durden DL, et al. Ceramide signaling in fenretinide-induced endothelial cell apoptosis. J Biol Chem 2002; 277:49531-7. [PMID 12388538]
18. Shimabukuro M, Zhou YT, Levi M, Unger RH. Fatty acid-induced beta cell apoptosis; a link between obesity and diabetes. Proc Natl Acad Sci USA 1998; 95:2498-502. [PMID 9482914]
19. Kelpe CL, Moore PC, Parazzoli SD, Wicksteed B, Rhodes CJ, Poitout V. Palmitate inhibition of insulin gene expression is mediated at the transcriptional level via ceramide synthesis. J Biol Chem 2003; 278:30015-21. [PMID 12771145]
20. Kowluru A. Novel regulatory roles for protein phosphatase 2A in the islet beta cell. Biochem Pharmacol 2005; 69:1681-91. [PMID 15935144]
21. Sjoholm A. Ceramide inhibits pancreatic beta-cell insulin production and mitogenesis and mimics the actions of interleukin 1beta. FEBS Lett 1995; 367:283-6. [PMID 7607324]
22. Sjoholm A. Aspects of the involvement of interleukin-1 and nitric oxide in the pathogenesis of insulin-dependent diabetes mellitus. Cell Death Differ 1998; 5:461-8. [PMID 10200497]
23. Welsh N. Interleukin-1 beta-induced ceramide and diacylglycerol generation may lead to activation of the c-Jun NH2-terminal kinase and the transcription factor ATF2 in the insulin-producing cell line RINm5F. J Biol Chem 1996; 271:8307-12. [PMID 8626526]
24. Kwon G, Bohrer A, Han X, Corbett JA, Ma Z, Gross RW, et al. Characterization of the sphingomyelin content of isolated pancreatic islets. Evaluation of the role of sphingomyelin hydrolysis in the action of interleukin-1 to induce islet overproduction of nitric oxide. Biochim Biophys Acta, 1996; 1300:63-72. [PMID 8608164]
25. Saldeen J, Jaffrezou JP, Welsh N. The acid sphingomyelinase inhibitor SR33557 counteracts TNF-alpha-mediated potentiation of IL-1beta-induced NF-kappaB activation in the insulin-producing cell line Rinm5F. Autoimmunity 2000; 32:241-54. [PMID 11191283]
26. Major CD, Gao ZY, Wolf BA. Activation of the sphingomyelinase/ceramide signal transduction pathway in insulin-secreting beta-cells: role in cytokine-induced beta cell death. Diabetes 1999; 48:1372-80. [PMID 10389841]
27. Jangati GR, Veluthakal R, Kowluru A. siRNA-mediated depletion of endogenous protein phosphatase 2Acalpha markedly attenuates ceramide-activated protein phosphatase activity in insulin-secreting INS-832/13 cells. Biochem Biophys Res Commun 2006; 348:649-52. [PMID 16884689]